First Rounders - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

First Rounders — Natural Sciences
First Rounders

Nature Biotechnology‘s First Rounders podcast is a series of conversations with founders, financers and developers from biotech’s past, present and future.

Hosted on Acast. See acast.com/privacy for more information.

Copyright: © 2019 Springer Nature 878632

Latest Episodes:

First Rounder: Jeff Leiden Feb 20, 2018

Show notes

Jeff Leiden is chairman, president and CEO of Vertex Pharmaceuticals. His conversation with Nature Biotechnology covers rebuilding Vertex toward cystic fibrosis, competing for talent in the innovation economy and dropping out of high school to enter college early.

Hosted on Acast. See acast.com/privacy for more information.

First Rounder: Susan Windham-Bannister Dec 18, 2017

Show notes

Susan Windham-Bannister is president and CEO of Biomedical Growth Strategies and was the founding president and CEO of the Massachusetts Life Sciences Center (MLSC). Her conversation with Nature Biotechnology covers her childhood in segregated St. Louis, her work at MLSC helping grow the life sciences sector in Massachusetts through Governor Deval Patrick's $1-billion initiative, and race relations in Boston and the United States.

Hosted on Acast. See acast.com/privacy for more information.

First Rounder: Stelios Papadopoulos Oct 26, 2017

Show notes

Stelios Papadopoulos has been a biotech analyst, investment banker, and company founder. He's the current chairman of the board at Biogen. His conversation with Nature Biotechnology touches on his reasons for leaving Greece to come to the United States, how he made his mark in the nascent biotech analyst field, and his participation in late '60s radicalism.

Hosted on Acast. See acast.com/privacy for more information.

First Rounder: Greg Winter Aug 18, 2017

Show notes

Greg Winter is the Master of Trinity College, Cambridge, and a serial entrepreneur, who co-founded Cambridge Antibody Technology. Much of his career was spent at the Medical Research Council, and his research led to humanized monoclonal antibodies. His conversation with Nature Biotechnology covers growing up in west Africa, how suffering an attack in the street led to a breakthrough in the lab, and the state of UK biotech.

Hosted on Acast. See acast.com/privacy for more information.

First Rounder: Jan Vilcek Jun 08, 2017

Show notes

Jan is the co-founder, CEO and chairman of the Vilcek Foundation, and also a long-time researcher and professor at New York University's School of Medicine. His conversation with Nature Biotechnology covers his harrowing childhood in Czechoslovakia during the rise of Nazi Germany and World War II, his escape from communist Czechoslovakia through defection, and his role in the discovery of the blockbuster drug Remicade.

Hosted on Acast. See acast.com/privacy for more information.

First Rounder: Rachel Haurwitz Apr 26, 2017

Show notes

Rachel Haurwitz is co-founder, president and CEO of Caribou Biosciences. In her discussion with Nature Biotechnology, she explains what drew her into the sciences, how her father's journalism career brought their family to Austin, Texas, and how she found herself at the cutting edge of CRISPR technology.

Hosted on Acast. See acast.com/privacy for more information.

First Rounder: Stephen Quake Feb 23, 2017

Show notes

Stephen Quake is a professor in the department of bioengineering at Stanford University and a serial founder of biotech companies. His talk with Nature Biotechnology covers launching Fluidigm, being chosen as copresident of the Chan Zuckerberg Biohub, and what it was like to be one of the first people to have their genome sequenced.

Hosted on Acast. See acast.com/privacy for more information.

First Rounder: Jeremy Levin Dec 20, 2016

Show notes

Jeremy Levin is chairman and CEO of Ovid Therapeutics, formerly president and CEO of Teva Pharmaceutical Industries, and former member of the executive committee at Bristol-Myers Squibb, where he led that company's 'string of pearls' strategy. His conversation with Nature Biotechnology covers shifting his mindset from treating patients to business development, his youth in South Africa, and how his past influences his view of the 2016 US presidential election results.

Hosted on Acast. See acast.com/privacy for more information.

First Rounder: Anu Acharya Nov 17, 2016

Show notes

Anu Acharya is founder and CEO of Mapmygenome, a co-founder of Ocimum Biosolutions and a leading light for life science entrepreneurship in India. Her discussion with Nature Biotechnology covers the importance of mentorship, running a consumer genomics company, and grieving the death of a parent.

Hosted on Acast. See acast.com/privacy for more information.

First Rounder: Nancy J Kelley Sep 22, 2016

Show notes

Nancy J Kelley, founder and chief executive of Nancy J Kelley + Associates, a consultancy creating and developing projects and institutions for science and medicine, touches on establishing the East River Science Park, excelling at Yale as a young mother of three and why one must take risks in life.

Hosted on Acast. See acast.com/privacy for more information.

Related Podcasts